Download | < Back |
21 Aug 2022 | |
Update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements, 2015) regarding approval for Meropenem Injection 500mg per vial and 1gram per vial (the product) from the United States Food & Drug Administration (USFDA) | |
View all announcements for BROOKS LABORATORIES LTD. | Source: BSE India |